Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD Module 3: Improving Adherence, Monitoring, and Communication
This activity, the third in a 3-part series, outlines commonly occurring extraintestinal manifestations of IBD and the primary care provider's role in identifying/investigating them.
Member: Free | Nonmember: Free

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD

 

Module 3: Improving Adherence, Monitoring, and Communication

Bret A. Lashner, MD; Elliot B. Davidson, MD, FAAFP

Inflammatory bowel disease is commonly associated with a wide range of extraintestinal manifestations that may appear in a variety of locations throughout the body. This activity, the third in a 3-part series, will review these manifestations and the primary care clinician’s role in identifying/investigating them. It will also examine patient non-adherence to medication and offer suggestions for fostering good communication with both patients and specialists.

Educational Objectives

Upon completion of this educational activity, the participant should be able to:
  • Review the most commonly occurring extraintestinal manifestations, the need to monitor for them, and managing them if they occur.
  • Delineate common reasons for patients’ non-adherence to prescribed medication and discuss strategies for improving adherence.
  • Implement strategies to improve communication with patients and IBD specialists.

Accreditation Statement

This activity has been reviewed and is approved for a maximum of 0.75 AAPA Category 1 CME credit by the AAPA Review Panel. Participants should only claim credit commensurate with their participation in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs. Approval is valid until October 31, 2017.

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Bret A. Lashner, MD
Professor of Medicine
Center for Inflammatory Bowel Disease
Department of Gastroenterology and Hepatology
Cleveland Clinic
Cleveland, OH
No relationship to disclose

Elliot B. Davidson, MD, FAAFP
Program Director, Family Medicine Residency
Cleveland Clinic Akron General
Director, Center for Family Medicine
Akron, OH
No relationship to disclose

Reviewers

Lauren Carruth, MD
New Jersey Academy of Family Physicians
No relationship to disclose

Alana R. Wichmann, APN
American Association of Nurse Practitioners
Speaker's Bureau-AbbVie, Inc

Eric Peterson, EdM, FACEHP, CHCP
American Academy of PAs
Salary-AAPA

Program Developer/Facilitator

Developed by the New Jersey Academy of Family Physicians (NJAFP), the American Association of Nurse Practitioners (AANP), and the American Academy of PAs (AAPA) in cooperation with MCM Education.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer

The opinions expressed in this presentation are those of the speaker and do not necessarily reflect the opinions or recommendations of their affiliated institutions; the publisher, the New Jersey Academy of Family Physicians (NJAFP), the American Association of Nurse Practitioners (AANP), and the American Academy of PAs (AAPA); Shire, AbbVie, Inc. or Salix Pharmaceuticals.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Shire, AbbVie, Inc. and Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America, LLC.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.


Type:     Internet Activity (Enduring Material)
522 Registered Users